Imagistix Inc., Ontario, Canada, – is a frequency and high resolution ultrasound imaging system that will revolutionize the detection and treatment of prostate cancer – the most common cancer in men. In a recent clinical study at John Hopkins, the number one hospital in urology, there was a 73 percent improvement in prostate cancer detection using the Imagistix system. Current low resolution imaging systems do not allow proper visualization of the prostate, resulting in two out of five men with prostate cancer being misdiagnosed (missed) on initial biopsy. The Imagistx high resolution system enables practitioners to visualize ducts and glands, locate cancerous regions, conduct targeted biopsies and monitor cancer evolution.
Yorn LLC, Philadelphia, Pennsylvania – is designed to enable patients, family members, and clinical staff to provide real-time feedback on any healthcare experience using any mobile device. Providers and payers can identify root causes of issues and make appropriate operational changes that improve patient experience and satisfaction. Yorn delivers clinical and economic benefits that can correlate to higher quality ratings on performance, isolate negative feedback from social media, enhance healthcare experiences and influence outcomes for all populations.
Guardian8, Scottsdale, Arizona - Guardian 8 produces enhanced non-lethal devices specifically designed to fit the needs of the security industry and the legal risks they often face. The company’s first product, the G8 Pro V2 establishes overlapping protection zones with increasing levels of non-lethal response. Its thoughtful collection of prov
Copyright©2012 Vocus, Inc.
All rights reserved